Brain Activity During Sexual Behavior in Patients With Primary Premature Ejaculation a Clinical Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-45
SponsorXijing Hospital

About this trial

This is a controlled study of patients with and without primary premature ejaculation. It is based on near-infrared spectroscopy (NIRS) functional brain imaging to detect and compare changes in brain activity in resting and task states (Simulated Sex) between the two groups of patients.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

patients' age varied from 18 to 45 years;

patients met the 2014 International Society for Sexual Medicine (ISSM) definition criteria for PPE;

patients had a stable, heterosexual relationship with a single sexually active female partner for at least 6 months and with at least two sexual intercourses a week and kept stable during the study period;

Patients with premature ejaculation lasting longer than 6 months;

Disqualifiers

patients were diagnosed with secondary PE, variable PE, and subjective PE;

patients were using medications for endocrinological, metabolic, chronic systemic, or psychiatric diseases;

patients were abusing alcohol or illegal drugs;

patients were diagnosed with erectile dysfunction (ED) if their scores were <21 on the abridged five-item International Index of Erectile Function (IIEF-5)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Detecting Brain Activity with Functional Near Infrared Spectroscopy

    Diagnostic test

    Use a functional near-infrared spectroscopy to detect brain activity in the two groups of subjects during resting state and task state.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: premature ejaculation groupExperimental treatment 1 intervention
Group B: Non-premature ejaculation groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Results of near-infrared brain functional imaging

Data on changes in oxygenated hemoglobin concentration

Time frame
1 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.